ASL 1 Abruzzo Awards €30.3 Million Vascular Devices Framework

Standfirst

A diverse group of specialized medical device suppliers has been awarded framework agreements totaling approximately 16 million euros to supply vascular surgery equipment to ASL 1 Avezzano Sulmona L'Aquila in Italy. The procurement is divided into 46 distinct lots covering biological patches, vascular prostheses, endoprostheses, and specialized catheters.

This tender result underscores the Italian public healthcare sector commitment to securing high quality clinical supplies through competitive open procedures. The multi supplier approach ensures clinical continuity and mitigates supply chain risks for regional hospitals.

Introduction

The continuous modernization of regional healthcare infrastructure requires a reliable and high quality supply of specialized medical devices. In the Abruzzo region of Italy, the local health authority has initiated a major procurement strategy to equip its vascular surgery units with advanced surgical tools and implants. This recent contract award ensures that medical professionals have access to the latest technologies required for complex vascular interventions.

By executing this procurement through a transparent open procedure, the contracting authority ensures compliance with national public procurement regulations while fostering competition among top tier medical device manufacturers. The selection of multiple suppliers across numerous specialized lots allows the health authority to mitigate supply chain risks and guarantee clinical continuity. This approach guarantees that public funds are deployed efficiently, fostering a competitive market for Active Tenders in the medical device sector.

Why This Contract Matters

This procurement is vital for ensuring that regional hospitals can perform life saving vascular surgeries without interruption due to equipment shortages. The inclusion of stringent technical evaluation criteria ensures that patient safety and clinical efficacy remain the top priorities. For the medical device industry, securing a position in this official Tenders Portal validates the technical superiority of the awarded products. It also demonstrates how public procurement can drive market innovation by rewarding suppliers who meet rigorous clinical standards.

Contract Timeline

The evaluation process concluded with the selection of winning suppliers on September 14, 2026. Following standard administrative procedures, the formal contracts were concluded on September 15, 2026.

The official contract awards notice was published in the Official Journal of the European Union on September 16, 2026. This timeline reflects a standard and transparent execution of public procurement regulations in the Italian healthcare sector.

Contract Overview

The procurement is structured as a four year framework agreement without reopening of competition, divided into 46 distinct lots. The maximum estimated value of the framework agreements is approximately 30.3 million euros, with the awarded portion totaling around 16 million euros.

The agreement covers a wide range of vascular surgery supplies, including biological patches, precoagulated vascular prostheses, aortic endoprostheses, and specialized catheters. Suppliers are required to deliver these products under a deposit account model, ensuring immediate availability for clinical use.

Key Contract Details

Project Scope

The core scope involves the supply of highly specialized medical devices for vascular surgery units. This includes biological vascular patches, open precoagulated vascular prostheses, custom made endoprostheses, and intravascular lithotripsy devices.

The suppliers must ensure all products comply with European medical device regulations and meet the specific technical requirements outlined in the bidding documents. The framework structure allows the health authority to draw upon these supplies as needed over the four year duration.

About the Contracting Authority

ASL 1 AVEZZANO SULMONA L'AQUILA is the primary contracting authority. It is a regional public health authority responsible for managing healthcare services and medical procurement within the provinces of L'Aquila, Avezzano, and Sulmona in the Abruzzo region of Italy.

About the Organisations Involved

ASL 1 AVEZZANO SULMONA L'AQUILA is the primary contracting authority and buyer. It manages regional healthcare services and drives the procurement of essential medical supplies for public hospitals.

W.L.GORE & ASSOCIATI SRL is a successful bidder and large economic operator. It secured multiple lots including vascular prostheses and endoprostheses, demonstrating strong market presence.

Getinge Italia is a successful bidder and large economic operator. It secured lots for precoagulated vascular prostheses, providing critical surgical implants.

LEMAITRE VASCULAR SRL is a successful bidder. It provides biological vascular patches and specialized catheters for complex vascular procedures.

H.D. HEALTH DEFENCE S.R.L. is a successful bidder. It was awarded contracts for abdominal aortic endoprostheses, ensuring advanced treatment options.

TECNOSTIM S.R.L. is a successful bidder. It supplies custom made and thoracoabdominal endoprostheses for specialized surgical needs.

Serom Medical Technology Srl is a successful bidder. It provides various vascular prostheses and endoprostheses to support regional hospitals.

MEDTRONIC ITALIA S.P.A is a successful bidder. It was awarded lots for vascular endoprostheses and radiofrequency catheters.

M.V.S. S.R.L. is a successful bidder. It supplies thoracic aortic exclusion prostheses and vascular catheters.

NEW TECH is a successful bidder. It provides large caliber vascular introducers and thromboaspiration devices.

Sintec srl is a successful bidder. It was awarded lots for large caliber vascular introducers and intravascular lithotripsy devices.

STARMED SRL is a successful bidder. It supplies vascular introducers and radiofrequency catheters for peripheral interventions.

Abbott Medical Italia S.r.l. is a successful bidder. It provides precutaneous closure systems for medium caliber arterial accesses.

NEOVASC is a successful bidder. It supplies heparin bonded self expanding vascular endoprostheses.

Bentley InnoMed GmbH is a successful bidder. It provides heparin bonded self expanding vascular endoprostheses from Germany.

BECTON DICKINSON ITALIA S.P.A. is a successful bidder. It supplies PTFE pledgets for surgical applications.

SVAS BIOSANA S.p.A. is a successful bidder. It provides rapid snap hemostatic valves.

Balt Italy s.r.l. is a successful bidder. It supplies rapid snap hemostatic valves for vascular access.

TECNICA SCIENTIFICA SERVICE SRL is a successful bidder. It provides procedural kits for difficult wound treatment.

GADA ITALIA SPA is a successful bidder. It supplies intravascular lithotripsy devices for calcified lesions.

F.A.S.E. is a successful bidder. It provides strippers for lower limb varicose veins.

Assut Europe spa is a successful bidder. It supplies biological vascular patches and PTFE pledgets.

Studio Pacinotti S.r.l. is a successful bidder. It provides steerable armed introducers for complex procedures.

ZUCCATO HC SRL is a successful bidder. It supplies procedural kits for difficult wound treatment.

Shockwave Medical Italy s.r.l. is a successful bidder. It provides intravascular lithotripsy devices.

B. Braun Milano SpA is a successful bidder. It supplies antimicrobial treated vascular prostheses and varicose vein strippers.

EDWARDS LIFESCIENCES ITALIA SRL is a successful bidder. It provides Fogarty catheters for embolectomy.

NEW ORTHO SRL is a successful bidder. It supplies procedural kits for difficult wound treatment.

TAR L' Aquila is the review organisation. This administrative court handles any legal appeals or disputes related to public procurement in the region.

ANAC AUTORITA NAZIONALE ANTICORRUZIONE is the procurement service provider. It oversees the integrity and transparency of the public procurement process.

Procurement Analysis

The open procedure attracted varying levels of competition across the 46 lots, with bid counts ranging from one to ten submissions per lot. The evaluation criteria utilized a most economically advantageous tender approach, assigning a 70 percent weight to technical quality and 30 percent to price.

This balanced evaluation method indicates that the technical and clinical baselines were strict, ensuring that only highly capable firms with proven track records could advance. Consequently, the competition focused on delivering optimal clinical value without compromising the quality of the medical devices provided.

Additional Procurement Facts

The procurement is not covered by the Government Procurement Agreement, reflecting its status as a domestic regional contract governed primarily by Italian national legislation. The project is not financed with European Union funds, relying entirely on the operational budget of the regional health authority.

Market & Industry Perspective

The Italian medical device market is characterized by a strong presence of established international and domestic manufacturers capable of meeting stringent public sector specifications. The success of multiple specialized firms highlights the importance of clinical efficacy and regulatory compliance in winning major public contracts.

Suppliers must continuously update their product lines to align with evolving medical standards and the specific requirements detailed in GPNs and BOQs. The dominance of specialized vascular device manufacturers in this space suggests that future RFPs and RFQs will continue to favor established contractors with proven clinical outcomes.

Economic Significance

An investment of approximately 16 million euros represents a substantial injection of capital into the regional healthcare supply chain. This spending supports local distribution networks and ensures that advanced medical technologies remain accessible to public health facilities.

By securing these supplies through long term frameworks, the public sector protects its clinical operations from short term market volatility.

Future Procurement Opportunities

Suppliers who were not successful should monitor the official Tenders Portal for upcoming medical device renewals in other Italian regions. As clinical guidelines evolve, public institutions will continuously generate new tenders opportunities for advanced surgical supplies and implants.

Stakeholders should also track the Latest Active Tenders Procurement notices to anticipate upcoming infrastructure projects in the broader European healthcare sector. The dynamic nature of public procurement means that new Live Notices for Tenders will emerge as regional authorities update their clinical requirements.

Opportunities for Suppliers

While the primary framework positions have been awarded, specialized logistics providers and medical device distributors can find valuable subcontracting opportunities with the primary winners. Companies offering advanced inventory management software or specialized cold chain transport may also position themselves to support the supply chain operations of the awarded firms.

What Businesses Should Watch

Industry observers should monitor the activation rates for each lot to gauge the actual clinical demand for specialized vascular devices in the Abruzzo region. The enforcement of strict technical evaluation criteria will be a key metric for future live tender evaluations in this sector.

Stakeholders should also review Live Notices for Tenders to anticipate upcoming medical modernization projects funded by national or regional health programs. Additionally, businesses should watch for any legal challenges filed with the review organisation, although none are indicated in the current notice.

ItalyTenders.com Procurement Intelligence

This contract represents a clear trend in European public procurement toward the use of multi supplier framework agreements for highly specialized medical devices. By appointing numerous suppliers across 46 distinct lots, the contracting authority mitigates the risk of supply chain bottlenecks and ensures broad market access for critical surgical tools. This strategy prioritizes operational continuity and strict adherence to clinical mandates over the traditional model of awarding exclusive contracts to a single provider.

Strategically, this award is important because it demonstrates how regional health authorities can leverage a balanced evaluation model to secure high quality solutions. The 70 percent weight assigned to technical quality signals that clinical efficacy and regulatory compliance are far more critical than marginal cost savings. Suppliers can learn that meeting these fundamental technical requirements is the primary gateway for winning public procurement contracts in the medical device sector.

Future contracts in this market are likely to evolve by incorporating even stricter material traceability and post market surveillance mandates. As public institutions face increasing pressure to ensure patient safety, companies that proactively develop transparent supply chains and offer verifiable clinical data will hold a distinct advantage. Suppliers must prepare for increased scrutiny on their product certifications, making robust documentation and compliance tracking essential for future public procurement success.

Supplier Takeaways

• Multi supplier framework agreements are increasingly used to guarantee supply chain resilience in public healthcare procurement.
• Meeting strict clinical and regulatory minimums is a primary gateway for winning government medical device contracts.
• Evaluation criteria heavily weighting technical quality require suppliers to maintain high product certification levels to pass initial qualification gates.
• Specialized logistics and distribution providers can find valuable subcontracting opportunities with primary framework winners.

Key Takeaways

• Multiple specialized suppliers were awarded positions across 46 distinct vascular surgery medical device lots.
• The maximum estimated value of the framework agreements is approximately 30.3 million euros.
• The award criteria balanced technical quality at 70 percent and price at 30 percent.
• The procurement ensures a four year supply of critical surgical implants and devices for regional hospitals.
• The framework agreements operate without reopening of competition, ensuring rapid order fulfillment for clinical needs.

Conclusion

This framework agreement secures a reliable and diversified supply of critical vascular surgery devices for the Abruzzo regional health system. The multi supplier award structure ensures competitive tension and operational resilience for the duration of the contract. As the region continues to modernize its healthcare delivery, this procurement model will likely serve as a blueprint for future medical acquisitions.

Source: Tenders Electronic Daily (TED), Contract Award Notice 637282-2026, Official Journal of the European Union, published on 16/09/2026.